✦ LIBER ✦

A phase II clinical trial of celecoxib combined with platinum-based regimen as first-line chemotherapy for advanced non-small cell lung cancer patients with cyclooxygenase-2 positive expression

✍ Scribed by Jun Zhao; Zhi-jie Wang; Jian-chun Duan; Qing-zhi Guo; Hua Bai; Lu Yang; Tong-tong An; Xin Wang; Yu-yan Wang; Mei-na Wu; Xu-yi Liu; Jie Wang

Publisher: Chinese Anti-Cancer Association
Year: 2009
Tongue: English
Weight: 521 KB
Volume: 21
Category: Article
ISSN: 1000-9604
DOI: 10.1007/s11670-009-0001-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of weekly chemotherapy

A phase II trial of weekly chemotherapy with paclitaxel plus gemcitabine as a first-line treatment in advanced non-small-cell lung cancer

✍ Kiyoshi Mori; Hiroyuki Kobayashi; Yukari Kamiyama; Yasuhiko Kano; Tetsuro Kodama 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 268 KB

Phase II trial of a 2-h infusion of gemc

Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer

✍ N. Xu; P. Shen; X. C. Zhang; L. F. Yu; H. Y. Bao; G. M. Shi; S. Huang; J. Chen; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 302 KB

Phase II study of weekly chemotherapy wi

Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy

✍ Kiyoshi Mori; Yukari Kamiyama; Tetsuro Kondo; Yasuhiko Kano; Tetsuro Kodama 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 330 KB

Weekly combination chemotherapy with doc

Weekly combination chemotherapy with docetaxel and gemcitabine as first-line treatment for elderly patients and patients with poor performance status who have extensive-stage small cell lung carcinoma : A Minnie Pearl Cancer Research Network Phase II Trial

✍ John D. Hainsworth; Donna Carrell; Ronald L. Drengler; Carroll Scroggin Jr.; F. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

## Abstract ## BACKGROUND The goal of the current study was to evaluate the feasibility, toxicity, and efficacy of a novel combination of weekly docetaxel and gemcitabine for elderly patients and patients with poor performance status who had advanced‐stage small cell lung carcinoma (SCLC). ## MET

A phase I/randomized phase II, non-compa

A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC)

✍ Roger B. Cohen; Corey J. Langer; George Rajan Simon; Peter David Eisenberg; John 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 387 KB